News FDA okays Italfarmaco’s non-steroidal DMD therapy Duvyzat Italfarmaco’s oral HDAC inhibitor givinostat has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD), becoming the first non-steroidal option for
News Pushback rises against RFK Jr's new ACIP membership Medical groups have criticised Robert F Kennedy Jr's newly constituted CDC vaccine advisory panel, calling for the previous experts to be reinstated.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face